Carbon Medical Technologies

Carbon Medical Technologies, Inc. (CMT) develops, manufactures and markets proprietary carbon-coated implantable medical devices. The biocompatibility of carbon makes it an ideal implant agent for numerous applications, including for soft tissue augmentation, tissue marking, and for vascular and neurological disorders. CMT's product pipeline includes devices in each of these areas, all of which serve large patient populations. CMT operates a fully functional ISO13485 certified and FDA-GMP approved manufacturing facility, has six issued patents and eight patent applications. CMT is a privately held St. Paul, Minnesota based company founded in 1994.